Peptides Codex
Home
Glycoprotein / activin-binding protein isoform

Follistatin-344

Follistatin-344 (FS-344) is the 344-amino-acid precursor isoform of follistatin, an activin-binding protein encoded by the FST gene. It antagonizes TGF-β superfamily ligands such as myostatin and activin, making it a focus of muscle-biology research. It is not an approved therapeutic in Canada.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
344 aa
Class
Glycoprotein / activin-binding protein isoform
Function
Binds and neutralizes TGF-β family ligands including myostatin and activin
Context
Research protein studied in muscle biology; not an approved drug in Canada

The myostatin-binding follistatin isoform behind muscle-growth research interest.

Also known as: FS-344 · FST-344 · follistatin precursor

Part of the Growth hormone & IGF peptides cluster

Overview

Follistatin-344 (FS-344) is the 344-amino-acid precursor isoform of follistatin, an activin-binding protein encoded by the FST gene. It antagonizes TGF-β superfamily ligands such as myostatin and activin, making it a focus of muscle-biology research. It is not an approved therapeutic in Canada.

Source & context

Biological / chemical source: Encoded by the human FST gene (344-residue precursor isoform)

Primary research or clinical context: Research protein studied in muscle biology; not an approved drug in Canada

Follistatin biology

Follistatin is an activin-binding glycoprotein that neutralizes several TGF-β superfamily ligands, most notably myostatin (GDF-8), a negative regulator of muscle mass. The FST gene is alternatively spliced; the 344-residue precursor (FS-344) is processed after signal-peptide removal into shorter circulating isoforms such as FS-315.

Why it draws search interest

Because myostatin restrains muscle growth, follistatin's ability to bind myostatin drives strong interest in muscle and performance contexts. Much of the compelling data comes from animal models and early gene-therapy studies rather than large human trials, so claims should be read cautiously.

Peptide vs protein note

Follistatin-344 is a full protein, not a short synthetic peptide, which affects how it is produced, delivered, and studied. Research programs have explored gene-therapy delivery of FS-344 rather than simple injection. This page is educational and offers no dosing or treatment advice.

FAQ about Follistatin-344

What is Follistatin-344?+

Follistatin-344 (FS-344) is the 344-amino-acid precursor isoform of follistatin, an activin-binding protein encoded by the FST gene. It antagonizes TGF-β superfamily ligands such as myostatin and activin, making it a focus of muscle-biology research. It is not an approved therapeutic in Canada.

Is Follistatin-344 an approved medicine?+

Follistatin-344 is discussed here as a research / educational topic. Research protein studied in muscle biology; not an approved drug in Canada. This is not medical advice.

What is the typical length of Follistatin-344?+

Follistatin-344 is commonly described as approximately 344 amino acids (Glycoprotein / activin-binding protein isoform).

Related peptides

References & further reading

  1. 1.Wikipedia — Follistatin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Follistatin-344 educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.